BOSTON IMMUNE TECHNOLOGIES & THERAPEUTICS
BITT has developed a platform for targeting the tumor necrosis factor receptor 2 (TNFR2) oncogene and the potent population of TNFR2 Tregs in the tumor microenvironment.
BOSTON IMMUNE TECHNOLOGIES & THERAPEUTICS
Industry:
Biotechnology Therapeutics
Founded:
2011-01-01
Address:
Winchester, Virginia, United States
Country:
United States
Website Url:
http://www.bostonimmunetech.com
Total Employee:
1+
Status:
Active
Total Funding:
10 M USD
Technology used in webpage:
SPF Content Delivery Network Font Awesome Microsoft Exchange Online Office 365 Mail IPv6 BootstrapCDN Cloudflare Hosting Cloudflare DNS
Current Advisors List
Current Employees Featured
Founder
Investors List
BeiGene
BeiGene investment in Series A - Boston Immune Technologies & Therapeutics
Hatteras Venture Partners
Hatteras Venture Partners investment in Series A - Boston Immune Technologies & Therapeutics
Official Site Inspections
http://www.bostonimmunetech.com Semrush global rank: 5.42 M Semrush visits lastest month: 1.56 K
- Host name: 186.27.212.35.bc.googleusercontent.com
- IP address: 35.212.27.186
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
Loading ... 